Citalopram for agitation in Alzheimer's disease: Design and methods-Reference-Cited by-同舟云学术

Citalopram for agitation in Alzheimer's disease: Design and methods

Published:2012-02-03 Issue:2 Volume:8 Page:121-130
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Drye Lea T.¹,Ismail Zahinoor²,Porsteinsson Anton P.³,Rosenberg Paul B.⁴,Weintraub Daniel⁵,Marano Christopher⁴,Pelton Gregory⁶,Frangakis Constantine¹,Rabins Peter V.⁴,Munro Cynthia A.⁴,Meinert Curtis L.¹,Devanand D.P.⁶,Yesavage Jerome⁷,Mintzer Jacobo E.⁸,Schneider Lon S.⁹,Pollock Bruce G.²,Lyketsos Constantine G.⁴,

Affiliation:

1. Departments of Epidemiology and BiostatisticsJohns Hopkins Bloomberg School of Public HealthBaltimoreMDUSA

2. Division of Geriatric PsychiatryUniversity of TorontoTorontoONCanada

3. Department of PsychiatryUniversity of Rochester School of Medicine and DentistryRochesterNYUSA

4. Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine and Division of Geriatric Psychiatry and NeuropsychiatryJohns Hopkins Bayview Medical CenterBaltimoreMDUSA

5. Department of PsychiatryUniversity of Pennsylvania School of MedicinePhiladelphiaPAUSA

6. Division of Geriatric PsychiatryNew York State Psychiatric Institute and College of Physicians and Surgeons of Columbia UniversityNew YorkNYUSA

7. Medical Research Service of the Veterans Affairs Palo Alto Health Care System, Department of Veterans Affairs, Sierra‐Pacific Mental Illness Research, Education, and Clinical Center (MIRECC), and Department of Psychiatry and Behavioral SciencesStanford University School of MedicinePalo AltoCAUSA

8. Department of NeurosciencesMedical University of South Carolina and Ralph H Johnson VA Medical CenterCharlestonSCUSA

9. Departments of Psychiatry and the Behavioral Sciences and NeurologyUniversity of Southern California Keck School of Medicine and the University of Southern California Leonard Davis School of GerontologyLos AngelesCAUSA

Funder

National Institute on Aging

National Institute of Mental Health

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2011.01.007

Reference59 articles.

1. Treatment of agitation in AD: A randomized, placebo-controlled clinical trial

2. A randomized, placebo-controlled trial of thiothixene in agitated, demented nursing home patients'

3. Introduction to behavioural and psychological symptoms of dementia (BPSD);Finkel S;Int J Geriatr Psychiatry,2000

4. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment;Finkel SI;Int Psychogeriatr,1996

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuropsychiatric Symptoms of Major or Mild Neurocognitive Disorders;Geriatric Psychiatry;2024

2. Neuropsychiatric Symptoms of Alzheimer’s Disease: An Anatomic-Genetic Framework for Treatment Development;Journal of Alzheimer's Disease;2023-08-29

3. A 2023 update on the advancements in the treatment of agitation in Alzheimer’s disease;Expert Opinion on Pharmacotherapy;2023-03-28

4. The Rationale and Design of Behavioral Interventions for Management of Agitation in Dementia in a Multi-Site Clinical Trial;Journal of Alzheimer's Disease;2022-03-22

5. Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria;Alzheimer's & Dementia;2021-06-16